Kirke Weaver - Feb 28, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role
Gen. Counsel & Corp. Secy.
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kirke Weaver
Stock symbol
OGN
Transactions as of
Feb 28, 2023
Transactions value $
-$35,904
Form type
4
Date filed
3/2/2023, 04:40 PM
Previous filing
Jan 10, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise +4.62K +201.05% 6.91K Feb 28, 2023 Direct F1
transaction OGN Common Stock Tax liability -$35.9K -1.43K -20.7% $25.09 5.48K Feb 28, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -4.62K -100% $0.00* 0 Feb 28, 2023 Common Stock 4.62K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into one share of Organon & Co. common stock.
F2 As originally reported on the Form 3, dated January 10, 2023, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023.